Gass JD, Guerry RK, Jack RL, Harris G. Choroidal osteoma. Arch Ophthalmol.1978;96:428-435
Shields CL, Sun H, Demirci H, Shields JA. Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes with choroidal osteoma. Arch. Ophthalmol. 2005;123:1658-1666.
Aylward GW, Chang TS, Pautler SE, Gass JD. A long-term follow-up of choroidal osteoma. Arch Ophthalmol. 1998;116:1337-1341.
Alameddine RM, Mansour AM, Kahtani E. Review of choroidal osteomas. Middle East African Journal of Ophthalmology, 2014,21(3):244-250.
Sharma S, Sribhargava N, Shanmugam MP. Choroidal neovascular membrane associated with choroidal osteoma (CO) treated with trans-pupillary thermotherapy. Indian J Ophthalmol. 2004;52:329e330.
Foster BS, Fernandez-Suntay JP, Dryja TP, Jakobiec FA, D’Amico DJ. Surgical removal and histopathologic findings of a subfoveal neovascular membrane associated with choroidal osteoma. Arch. Ophthalmol. 2003;121:273e276.
Jang JH, Kim KH, Lee SJ, Park JM. Photodynamic therapy combined with intravitreal bevacizumab in a patient with choroidal neovascularization secondary to choroidal osteoma. Korean J Ophthalmol KJO. 2012;26:478e480.
Mansour AM, Arevalo JF, Al Kahtani E, et al. Role of intravitreal antivascular endothelial growth factor injections for choroidal neovascularization due to choroidal osteoma. J Ophthalmol. 2014;2014:210458.
Agarwal M, Kantha M, Mayor R, Venkatesh R, Shroff CM. Bilateral choroidal osteoma with choroidal neovascular membrane treated with bevacizumab in a child. Middle East Afr J Ophthalmol. 2014;21:265-267.
S. Zafar et al. Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma. American Journal of Ophthalmology Case Reports 4 (2016) 7-10
Papastefanou VP, Pefkianaki M, Al Harby L, Arora AK, Cohen VM, Andrews RM, Sagoo MS. Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma. Eye (Lond). 2016 Jun;30(6):843-9.
Ahmadieh H, Vafi N. Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab(Avastin). Graefe’s Arch. Clin Exp Ophthalmol. 2007;245:1731e1733.
Lekha T, Renuka N, Prasad H. Anti-vascular Endothelial Growth Factors for Choroidal Neovascularization Secondary to Choroidal Osteoma: Long-term Results. Oman J Ophthalmol.2015,Sep-Dec;8(3):185-7.
Behera M, Das MK. A case of choroidal osteoma in a 10-year-old child. Int Med Case Rep J. 2015;8:273e275.
Liu K, Song Y, Xu G, Ye J, Wu Z, Liu X, Dong X, Zhang M, Xing Y, Zhu S, Chen X, Shen Y, Huang H, Yu L, Ke Z, Rosenfeld PJ, Kaiser PK, Ying G, Sun X, Xu X; PHOENIX study group.Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX study. Am J Ophthalmol. 2018 Aug 24. pii: S0002-9394(18)30478-1.
Yan M, Huang Z, Lian HY, Song YP, Chen X. Conbercept for treatment of choroidal neovascularization secondary to pathologic myopia.Acta Ophthalmol. 2018 Sep 5.
Bai Y, Nie H, Wei S, Lu X, Ke X, Ouyang X, Feng S.Efficacy of intravitreal conbercept injection in the treatment of retinopathy of prematurity.Br J Ophthalmol. 2018 Jul 20.